Matilde Sanchez

2.7k total citations · 3 hit papers
12 papers, 2.0k citations indexed

About

Matilde Sanchez is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Matilde Sanchez has authored 12 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Matilde Sanchez's work include Pharmacology and Obesity Treatment (6 papers), Hormonal and reproductive studies (4 papers) and Muscle metabolism and nutrition (2 papers). Matilde Sanchez is often cited by papers focused on Pharmacology and Obesity Treatment (6 papers), Hormonal and reproductive studies (4 papers) and Muscle metabolism and nutrition (2 papers). Matilde Sanchez collaborates with scholars based in United States, Spain and Czechia. Matilde Sanchez's co-authors include Christen M. Anderson, Steven R. Smith, William Shanahan, Neil J. Weissman, Meredith C. Fidler, Emil Chuang, Harold Bays, Jinkun Zhang, Patrick M. O’Neil and Nicolás Fiz and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and SLEEP.

In The Last Decade

Matilde Sanchez

12 papers receiving 1.8k citations

Hit Papers

Multicenter, Placebo-Controlled Trial of Lorcaserin for W... 2010 2026 2015 2020 2010 2011 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
    2010 677 citations Steven R. Smith, Neil J. Weissman et al. New England Journal of Medicine profile →
  2. A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
    2011 414 citations Meredith C. Fidler, Matilde Sanchez et al. The Journal of Clinical Endocrinology & Metabolism profile →
  3. Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
    2012 394 citations Patrick M. O’Neil, Steven R. Smith et al. Obesity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matilde Sanchez United States 10 1.4k 905 729 274 250 12 2.0k
Lisa Connery United States 5 889 0.6× 1.3k 1.5× 748 1.0× 484 1.8× 147 0.6× 10 2.1k
Mathijs C. Bunck United States 10 1.0k 0.7× 1.6k 1.8× 968 1.3× 578 2.1× 196 0.8× 21 2.7k
Domenica Rubino United States 23 1.6k 1.2× 2.3k 2.5× 989 1.4× 567 2.1× 190 0.8× 60 3.4k
Mark Boldrin United States 16 2.2k 1.6× 1.9k 2.1× 1.3k 1.7× 582 2.1× 217 0.9× 22 3.5k
Jana Böhnke Germany 12 636 0.5× 876 1.0× 819 1.1× 284 1.0× 150 0.6× 15 2.1k
Charles Lucas United States 20 1.3k 1.0× 1.4k 1.5× 890 1.2× 382 1.4× 154 0.6× 58 2.9k
Barbara Troupin United States 5 1.1k 0.8× 964 1.1× 667 0.9× 209 0.8× 104 0.4× 5 1.5k
Jean‐Pierre Gutzwiller Switzerland 17 298 0.2× 1.1k 1.2× 545 0.7× 637 2.3× 609 2.4× 27 2.2k
Zoltán Járai Hungary 20 2.4k 1.7× 684 0.8× 647 0.9× 740 2.7× 866 3.5× 75 3.6k
Christine B. Jensen Denmark 22 1.8k 1.3× 2.5k 2.8× 1.5k 2.1× 898 3.3× 265 1.1× 26 4.2k

Countries citing papers authored by Matilde Sanchez

Since Specialization
Citations

This map shows the geographic impact of Matilde Sanchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilde Sanchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilde Sanchez more than expected).

Fields of papers citing papers by Matilde Sanchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matilde Sanchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilde Sanchez. The network helps show where Matilde Sanchez may publish in the future.

Co-authorship network of co-authors of Matilde Sanchez

This figure shows the co-authorship network connecting the top 25 collaborators of Matilde Sanchez. A scholar is included among the top collaborators of Matilde Sanchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matilde Sanchez. Matilde Sanchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Christopher, Ronald, Michael Morgan, Yong Tang, et al.. (2017). Pharmacokinetics and Tolerability of Lorcaserin in Special Populations: Elderly Patients and Patients with Renal or Hepatic Impairment. Clinical Therapeutics. 39(4). 837–848.e7. 7 indexed citations
2.
Antonijevic, Zoran, Paul Gallo, Christy Chuang‐Stein, et al.. (2013). Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive Trials. Therapeutic Innovation & Regulatory Science. 47(4). 495–502. 9 indexed citations
3.
Weissman, Neil J., Matilde Sanchez, Gary G. Koch, et al.. (2013). Echocardiographic Assessment of Cardiac Valvular Regurgitation With Lorcaserin From Analysis of 3 Phase 3 Clinical Trials. Circulation Cardiovascular Imaging. 6(4). 560–567. 59 indexed citations
4.
O’Neil, Patrick M., Steven R. Smith, Neil J. Weissman, et al.. (2012). Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study. Obesity. 20(7). 1426–1436. 394 indexed citations breakdown →
5.
Fidler, Meredith C., Matilde Sanchez, Neil J. Weissman, et al.. (2011). A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial. The Journal of Clinical Endocrinology & Metabolism. 96(10). 3067–3077. 414 indexed citations breakdown →
6.
Sanchez, Matilde, Jorge Guadilla, Nicolás Fiz, & Isabel Andı́a. (2011). Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Lara D. Veeken. 51(1). 144–150. 137 indexed citations
7.
Smith, Steven R., Neil J. Weissman, Christen M. Anderson, et al.. (2010). Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management. New England Journal of Medicine. 363(3). 245–256. 677 indexed citations breakdown →
8.
Martin, Corby K., Leanne M. Redman, Jinkun Zhang, et al.. (2010). Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure. The Journal of Clinical Endocrinology & Metabolism. 96(3). 837–845. 111 indexed citations
9.
Peterson, Patrick, Kevin Carroll, Christy Chuang‐Stein, et al.. (2010). Response. Statistics in Biopharmaceutical Research. 2(4). 538–539. 1 indexed citations
10.
Úbeda, Amalia, et al.. (2009). Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication. Pharmacoepidemiology and Drug Safety. 18(5). 417–419. 20 indexed citations
11.
Rosenberg, Russell, David Seiden, Steven Hull, et al.. (2008). APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia. SLEEP. 31(12). 1663–1671. 33 indexed citations
12.
Leung, Albert, Kerstin Malmström, A Gallacher, et al.. (2002). Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial. Current Medical Research and Opinion. 18(2). 49–58. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Connery Breakdown of academic impact, for papers by Mathijs C. Bunck Breakdown of academic impact, for papers by Domenica Rubino Breakdown of academic impact, for papers by Mark Boldrin Breakdown of academic impact, for papers by Jana Böhnke Breakdown of academic impact, for papers by Charles Lucas Breakdown of academic impact, for papers by Barbara Troupin Breakdown of academic impact, for papers by Jean‐Pierre Gutzwiller Breakdown of academic impact, for papers by Zoltán Járai Breakdown of academic impact, for papers by Christine B. Jensen
Rankless by CCL
2026